West Pharmaceutical Services (FRA:WPS) Total Stockholders Equity : €2,466 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is West Pharmaceutical Services Total Stockholders Equity?

West Pharmaceutical Services's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €2,466 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. West Pharmaceutical Services's Book Value per Share for the quarter that ended in Mar. 2024 was €33.78. The ratio of a company's debt over equity can be used to measure how leveraged this company is. West Pharmaceutical Services's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.11.

West Pharmaceutical Services Total Stockholders Equity Historical Data

The historical data trend for West Pharmaceutical Services's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Pharmaceutical Services Total Stockholders Equity Chart

West Pharmaceutical Services Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

1,415.88

1,524.40

2,066.83

2,534.55

2,641.88

West Pharmaceutical Services Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															2,592.97	2,535.20	2,687.50	2,641.88	2,466.15

West Pharmaceutical Services (FRA:WPS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

West Pharmaceutical Services's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2466.152	-	0)	/	73
	=	33.78

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

West Pharmaceutical Services's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(139.288	+	142.784)	/	2466.152
	=	0.11

West Pharmaceutical Services Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of West Pharmaceutical Services's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

West Pharmaceutical Services (FRA:WPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » West Pharmaceutical Services Inc (FRA:WPS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

WST:USA WPS:Germany

Address

530 Herman O. West Drive, Exton, PA, USA, 19341-0645

Website

https://www.westpharma.com

West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.